Myeloid-derived suppressor cells (MDSCs) dampen the immune response thorough inhibition of T cell activation and proliferation and often are expanded in pathological conditions. Here, we studied the fate of MDSCs in cancer. Unexpectedly, MDSCs had lower viability and a shorter half-life in tumor-bearing mice compared with neutrophils and monocytes. The reduction of MDSC viability was due to increased apoptosis, which was mediated by increased expression of TNF-related apoptosis–induced ligand receptors (TRAIL-Rs) in these cells. Targeting TRAIL-Rs in naive mice did not affect myeloid cell populations, but it dramatically reduced the presence of MDSCs and improved immune responses in tumor-bearing mice. Treatment of myeloid cells with proinflammatory cytokines did not affect TRAIL-R expression; however, induction of ER stress in myeloid cells recapitulated changes in TRAIL-R expression observed in tumor-bearing hosts. The ER stress response was detected in MDSCs isolated from cancer patients and tumor-bearing mice, but not in control neutrophils or monocytes, and blockade of ER stress abrogated tumor-associated changes in TRAIL-Rs. Together, these data indicate that MDSC pathophysiology is linked to ER stress, which shortens the lifespan of these cells in the periphery and promotes expansion in BM. Furthermore, TRAIL-Rs can be considered as potential targets for selectively inhibiting MDSCs.
Thomas Condamine, Vinit Kumar, Indu R. Ramachandran, Je-In Youn, Esteban Celis, Niklas Finnberg, Wafik S. El-Deiry, Rafael Winograd, Robert H. Vonderheide, Nickolas R. English, Stella C. Knight, Hideo Yagita, Judith C. McCaffrey, Scott Antonia, Neil Hockstein, Robert Witt, Gregory Masters, Thomas Bauer, Dmitry I. Gabrilovich
Title and authors | Publication | Year |
---|---|---|
Designer extracellular vesicles with DR5-agonistic-scFvs simultaneously target tumor and immune suppressive cells in solid tumors
Yeye Guo, Huaishan Wang, Shujing Liu, Xiaogang Zhang, Xingyue Zhu, Lili Huang, Wenqun Zhong, Lei Guan, Yeqing Chen, Min Xiao, Lingling Ou, Jingbo Yang, Gerald Linette, Alexander Huang, Tara Mitchell, Ravi Amaravadi, Giorgos Karakousis, John Miura, Lynn Schuchter, Ahron Flowers, Qiuxian Zheng, Haiwei Mou, Phyllis Gimotty, Meenhard Herlyn, Wei Guo, Xiaowei Xu |
Science advances | 2025 |
Endoplasmic Reticulum Stress: Triggers Microenvironmental Regulation and Drives Tumor Evolution
Peng C, Wang J, Wang S, Zhao Y, Wang H, Wang Y, Ma Y, Yang J |
Cancer Medicine | 2025 |
Noncanonical TRAIL signaling promotes myeloid-derived suppressor cell abundance and
tumor progression in cholangiocarcinoma
Emilien Loeuillard, Binbin Li, Hannah Stumpf, Jingchun Yang, Jessica Willhite, Jennifer Tomlinson, Juan Wang, Fariborz Rakhshan Rohakhtar, Vernadette Simon, Rondell Graham, Rory Smoot, Haidong Dong, Sumera Ilyas |
Cellular and Molecular Gastroenterology and Hepatology | 2024 |
Myeloid-derived suppressor cells in cancer and cancer therapy.
Lasser SA, Ozbay Kurt FG, Arkhypov I, Utikal J, Umansky V |
Nature reviews. Clinical oncology | 2024 |
Targeting PMN-MDSCs via CD300ld receptor for cancer immunotherapy.
Li Y, Wang C, Lu Z, Luo M |
Clinical and Translational Medicine | 2024 |
粒细胞样髓源性抑制细胞在非小细胞肺癌中的研究进展
YANG C, ZHU R, ZHANG Y, YING L, WANG J, LIU P, SU D |
2024 | |
Immune cell networking in solid tumors: focus on macrophages and neutrophils.
Di Ceglie I, Carnevale S, Rigatelli A, Grieco G, Molisso P, Jaillon S |
Frontiers in immunology | 2024 |
Carbon Ion Irradiation Activates Anti-Cancer Immunity
Sudo M, Tsutsui H, Fujimoto J |
International journal of molecular sciences | 2024 |
MDSC expansion during HIV infection: regulators, ART and immune reconstitution.
Yaseen MM, Abuharfeil NM, Darmani H |
Genes and Immunity | 2024 |
Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion.
Lu J, Luo Y, Rao D, Wang T, Lei Z, Chen X, Zhang B, Li Y, Liu B, Xia L, Huang W |
Experimental Hematology and Oncology | 2024 |
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Niu Z, Wu J, Zhao Q, Zhang J, Zhang P, Yang Y |
Frontiers in immunology | 2024 |
Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma
Haizhen Luo, Naoki Ikenaga, Kohei Nakata, Nobuhiro Higashijima, Pingshan Zhong, Akihiro Kubo, Chenyi Wu, Chikanori Tsutsumi, Yuki Shimada, Masataka Hayashi, Koki Oyama, Satomi Date, Toshiya Abe, Noboru Ideno, Chika Iwamoto, Koji Shindo, Kenoki Ohuchida, Yoshinao Oda, Masafumi Nakamura |
Journal of experimental & clinical cancer research : CR | 2024 |
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y |
Journal of Hematology & Oncology | 2024 |
Knock down of APE1 suppressed gastric cancer metastasis via improving immune disorders caused by myeloid-derived suppressor cells
Zhang B, Tang Q, Shi W, Bao Z, Gao S, Pan C |
Cell cycle (Georgetown, Tex.) | 2024 |
Tumour Microenvironment: The General Principles of Pathogenesis and Implications in Diffuse Large B Cell Lymphoma
Sinkarevs S, Strumfs B, Volkova S, Strumfa I |
Cells | 2024 |
DDIT3 is associated with breast cancer prognosis and immune microenvironment: an integrative bioinformatic and immunohistochemical analysis
Yu X, Li W, Sun S, Li J |
Journal of Cancer | 2024 |
Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy
Zhang L, He X, Zhu H |
MedComm | 2024 |
PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma
Liu X, Liu M, Wu H, Tang W, Yang W, Chan TT, Zhang L, Chen S, Xiong Z, Liang J, Wai-Yiu Si-Tou W, Shu T, Li J, Cao J, Zhong C, Sun H, Kwong TT, Leung HH, Wong J, Bo-San Lai P, To KF, Xiang T, Jao-Yiu Sung J, Chan SL, Zhou J, Sze-Lok Cheng A |
2024 | |
Impact of obesity-associated myeloid-derived suppressor cells on cancer risk and progression (Review)
Jiménez-Cortegana C, Gutiérrez-García C, Sánchez-Jiménez F, Vilariño-García T, Flores-Campos R, Pérez-Pérez A, Garnacho C, Sánchez-León ML, García-Domínguez DJ, Hontecillas-Prieto L, Palazón-Carrión N, De La Cruz-Merino L, Sánchez-Margalet V |
International journal of oncology | 2024 |
The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies
Luo C, He S, Shi F, Zhou J, Shang L |
Biology | 2024 |
Dual roles of CD11b+CD33+HLA-DR-/lowCD14- myeloid-derived suppressor cells with a granulocytic morphology following allogeneic hematopoietic stem cell transplantation: from inflammation promoters to immune suppressors within 90 days
Ni M, Cui J, Yang X, Ding Y, Zhao P, Hu T, Zhan Y, Kang Q, Hu X, Zhao J, Xu Y, Chen L, Liu M, Zhao M, Zhang F, Huang S, Li Y, Yang X, Zhang L, Zhang T, Deng B, Yang B, Lu D, Wang J |
Frontiers in immunology | 2024 |
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review).
Zeng W, Liu H, Mao Y, Jiang S, Yi H, Zhang Z, Wang M, Zong Z |
International journal of oncology | 2024 |
Immunologic Crosstalk of Endoplasmic Reticulum Stress Signaling in Bladder Cancer.
Wan S, Li KP, Wang CY, Yang JW, Chen SY, Wang HB, Li XR, Yang L |
Current cancer drug targets | 2024 |
The role of neutrophils in osteosarcoma: insights from laboratory to clinic
Xia M, Han Y, Sun L, Li D, Zhu C, Li D |
Frontiers in Immunology | 2024 |
MDSC: a new potential breakthrough in CAR-T therapy for solid tumors
Abdalsalam NM, Ibrahim A, Saliu MA, Liu TM, Wan X, Yan D |
Cell Communication and Signaling : CCS | 2024 |
Endothelial YAP/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury
Zhang S, Sun Z, Chen Z, Bi Y, Wei S, Mao Z, Jin J, Ding Y, Wang W |
Hepatology (Baltimore, Md.) | 2024 |
Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease
Lou X, Gao D, Yang L, Wang Y, Hou Y |
Journal of Translational Medicine | 2023 |
The Receptor for Advanced Glycation Endproducts (RAGE) and Its Ligands S100A8/A9 and High Mobility Group Box Protein 1 (HMGB1) Are Key Regulators of Myeloid-Derived Suppressor Cells
Ostrand-Rosenberg S, Huecksteadt T, Sanders K |
Cancers | 2023 |
Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress
Andrés CM, Pérez de la Lastra JM, Juan CA, Plou FJ, Pérez-Lebeña E |
Human vaccines | 2023 |
5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL+ Cytotoxic T Lymphocyte Cytotoxicity
Yang Y, Zhang M, Zhang Y, Liu K, Lu C |
Cancers | 2023 |
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
Riera-Domingo C, Leite-Gomes E, Charatsidou I, Zhao P, Carrá G, Cappellesso F, Mourao L, De Schepper M, Liu D, Serneels J, Alameh MG, Shuvaev VV, Geukens T, Isnaldi E, Prenen H, Weissman D, Muzykantov VR, Soenen S, Desmedt C, Scheele CL, Sablina A, Di Matteo M, Martín-Pérez R, Mazzone M |
Science Advances | 2023 |
Neutrophil PAD4: how does it function in cancer beyond promoting NETosis?
Garcia-Gerique L, Nefedova Y |
Oncotarget | 2023 |
Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs.
Pinto NA, Abba MC, Laporte L, Pérez Sáez JM, Blidner AG, Torres NI, Morales RM, Gatto SG, Bach CA, Veigas F, García Rivello HJ, Song P, Frederiksen JH, Rasmussen LJ, Poirier F, Croci DO, Sundblad V, Rabinovich GA, Cerliani JP |
Cell Death and Differentiation | 2023 |
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
Bhardwaj V, Ansell SM |
Frontiers in Cell and Developmental Biology | 2023 |
Intranasal Delivery of Gene-Edited Microglial Exosomes Improves Neurological Outcomes after Intracerebral Hemorrhage by Regulating Neuroinflammation
Guo M, Ge X, Wang C, Yin Z, Jia Z, Hu T, Li M, Wang D, Han Z, Wang L, Xiong X, Chen F, Lei P |
Brain Sciences | 2023 |
Neutrophil diversity in inflammation and cancer
Carnevale S, Ceglie ID, Grieco G, Rigatelli A, Bonavita E, Jaillon S |
Frontiers in immunology | 2023 |
Schlafen4+-MDSC in Helicobacter-induced gastric metaplasia reveals role for GTPases
Ding L, Sheriff S, Sontz RA, Merchant JL |
Frontiers in immunology | 2023 |
Tumor-associated myeloid cells in cancer immunotherapy.
Cheng X, Wang H, Wang Z, Zhu B, Long H |
Journal of Hematology & Oncology | 2023 |
Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
Hieber C, Grabbe S, Bros M |
Biomolecules | 2023 |
Dose-related immunomodulatory effects of recombinant TRAIL in the tumor immune microenvironment.
Wang X, Wang L, Liu W, Liu X, Jia X, Feng X, Li F, Zhu R, Yu J, Zhang H, Wu H, Wu J, Wang C, Yu B, Yu X |
Journal of experimental & clinical cancer research : CR | 2023 |
Function of reactive oxygen species in myeloid-derived suppressor cells
Huang J, Zhao Y, Zhao K, Yin K, Wang S |
Frontiers in immunology | 2023 |
CD300ld on neutrophils is required for tumour-driven immune suppression.
Wang C, Zheng X, Zhang J, Jiang X, Wang J, Li Y, Li X, Shen G, Peng J, Zheng P, Gu Y, Chen J, Lin M, Deng C, Gao H, Lu Z, Zhao Y, Luo M |
Nature | 2023 |
TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content
Gunalp S, Helvaci DG, Oner A, Bursalı A, Conforte A, Güner H, Karakülah G, Szegezdi E, Sag D |
Frontiers in immunology | 2023 |
Exploiting innate immunity for cancer immunotherapy
Yi M, Li T, Niu M, Mei Q, Zhao B, Chu Q, Dai Z, Wu K |
Molecular Cancer | 2023 |
DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies
Giardino Torchia ML, Moody G |
Frontiers in immunology | 2023 |
Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential
Chamorro DF, Somes LK, Hoyos V |
Cancers | 2023 |
Modeling glioblastoma complexity with organoids for personalized treatments
Pawlowski KD, Duffy JT, Babak M, Balyasnikova IV |
Trends in Molecular Medicine | 2023 |
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression
Sean Colligan, Robert A Zollo, Jennifer Peresie, Elliot D Kramer, Joseph Barbi, Prashant K Singh, Jianmin Wang, Mateusz Opyrchal, David Sykes, Michael Nemeth, Scott I. Abrams |
Journal of Clinical Investigation | 2022 |
Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective
A Bleve, F Consonni, C Porta, V Garlatti, A Sica |
Cancers | 2022 |
Interaction of Immune and Cancer Cells
M Klink, I Szulc-Kielbik |
2022 | |
Neutrophils as potential therapeutic targets in hepatocellular carcinoma
D Geh, J Leslie, R Rumney, H Reeves, T Bird, D Mann |
Nature Reviews Gastroenterology & Hepatology | 2022 |
Anti-Gr-1 Antibody Provides Short-Term Depletion of MDSC in Lymphodepleted Mice with Active-Specific Melanoma Therapy
P Rose, N van den Engel, J Kovács, R Hatz, L Boon, H Winter |
Human vaccines | 2022 |
RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism
M Liu, H Zhang, L Zhang, X Liu, S Zhou, X Wang, W Zhong, J Zhang, B Wang, J Zhao, L Zhou |
International journal of biological sciences | 2022 |
Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in Glioblastoma
M Exley, S Garcia, A Zellander, J Zilberberg, D Andrews |
Journal of Clinical Medicine | 2022 |
Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment
P Allavena, C Belgiovine, E Digifico, R Frapolli, M DIncalci |
Frontiers in Oncology | 2022 |
PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen
M Liu, C Wu, S Luo, Q Hua, H Chen, Y Weng, J Xu, H Lin, L Wang, J Li, L Zhu, Z Guo, S Zhuang, T Kang, L Zheng |
Journal of Experimental Medicine | 2022 |
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study
P LoRusso, M Ratain, T Doi, D Rasco, M de Jonge, V Moreno, B Carneiro, L Devriese, A Petrich, D Modi, S Morgan-Lappe, S Nuthalapati, M Motwani, M Dunbar, J Glasgow, B Medeiros, E Calvo |
Investigational New Drugs | 2022 |
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
T Kim, E Vandsemb, R Herbst, L Chen |
Nature Reviews Drug Discovery | 2022 |
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang Q, Shen X, Chen G, Du J |
Cancers | 2022 |
Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
Joshi S, Sharabi A |
Pharmacology & Therapeutics | 2022 |
Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection
Li YN, Wang ZW, Li F, Zhou LH, Jiang YS, Yu Y, Ma HH, Zhu LP, Qu JM, Jia XM |
Nature Communications | 2022 |
Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition
Wei C, Ma Y, Wang F, Liao Y, Chen Y, Zhao B, Zhao Q, Wang D, Tang D |
Clinical Medicine Insights. Oncology | 2022 |
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.
Wu Y, Yi M, Niu M, Mei Q, Wu K |
Molecular Cancer | 2022 |
The soldiers needed to be awakened: Tumor-infiltrating immune cells
Yaping W, Zhe W, Zhuling C, Ruolei L, Pengyu F, Lili G, Cheng J, Bo Z, Liuyin L, Guangdong H, Yaoling W, Niuniu H, Rui L |
Frontiers in Genetics | 2022 |
Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers
Tang Y, Zhou C, Li Q, Cheng X, Huang T, Li F, He L, Zhang B, Tu S |
OncoImmunology | 2022 |
Anti-cancer immune responses to DNA damage response inhibitors: Molecular mechanisms and progress toward clinical translation
Carlsen L, El-Deiry WS |
Frontiers in Oncology | 2022 |
Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity.
Salvagno C, Mandula JK, Rodriguez PC, Cubillos-Ruiz JR |
Trends in Cancer | 2022 |
Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses.
Xu D, Liu S, Wu X, Marti TM, Dorn P, Schmid RA, Peng RW, Shu Y |
Cancers | 2022 |
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis.
Wang L, Jin H, Jochems F, Wang S, Lieftink C, Martinez IM, De Conti G, Edwards F, de Oliveira RL, Schepers A, Zhou Y, Zheng J, Wu W, Zheng X, Yuan S, Ling J, Jastrzebski K, Santos Dias MD, Song JY, Celie PNH, Yagita H, Yao M, Zhou W, Beijersbergen RL, Qin W, Bernards R |
2022 | |
Immunomodulatory biomaterials for implant-associated infections: from conventional to advanced therapeutic strategies
Dong J, Wang W, Zhou W, Zhang S, Li M, Li N, Pan G, Zhang X, Bai J, Zhu C |
Biomaterials Research | 2022 |
Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer
Chen X, Feng L, Huang Y, Wu Y, Xie N |
Cancers | 2022 |
Characteristics of tumor microenvironment and novel immunotherapeutic strategies for non-small cell lung cancer
Wang F, Yang M, Luo W, Zhou Q |
2022 | |
Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer
Evgenii N Tcyganov, Shino Hanabuchi, Ayumi Hashimoto, David Campbell, Gozde Kar, Timothy W F Slidel, Corinne Cayatte, Aimee Landry, Fernanda Pilataxi, Susana Hayes, Brian Dougherty, Kristin C. Hicks, Kathy Mulgrew, Chih-Hang A Tang, Chih-Chi A. Hu, Wei Guo, Sergei Grivennikov, Mohammed-Alkhatim A. Ali, Jean-Christophe Beltra, E. John Wherry, Yulia Nefedova, Dmitry I. Gabrilovich |
Journal of Clinical Investigation | 2021 |
Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
H Shi, K Li, Y Ni, X Liang, X Zhao |
Frontiers in Cell and Developmental Biology | 2021 |
Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment
Y Li, H He, R Jihu, J Zhou, R Zeng, H Yan |
Frontiers in Cell and Developmental Biology | 2021 |
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
K Li, H Shi, B Zhang, X Ou, Q Ma, Y Chen, P Shu, D Li, Y Wang |
Signal Transduction and Targeted Therapy | 2021 |
The role of myeloid‐derived suppressor cells in gastrointestinal cancer
C Cui, P Lan, L Fu |
2021 | |
Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
M Krishnamoorthy, L Gerhardt, SM Vareki |
Cells | 2021 |
Endoplasmic Reticulum Quality Control in Immune Cells
Y Jiang, Z Tao, H Chen, S Xia |
Frontiers in Cell and Developmental Biology | 2021 |
Tumor-related stress regulates functional plasticity of MDSCs
JK Mandula, PC Rodriguez |
Cellular Immunology | 2021 |
Unexpected PD‐L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies
T Mondal, GN Shivange, RG Tihagam, E Lyerly, M Battista, D Talwar, R Mosavian, K Urbanek, NS Rashid, JC Harrell, PD Bos, EB Stelow, MS Stack, S Bhatnagar, J TushirSingh |
EMBO Molecular Medicine | 2021 |
Roles of Neutrophils in Glioma and Brain Metastases
YJ Lin, KC Wei, PY Chen, M Lim, TL Hwang |
Frontiers in immunology | 2021 |
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
C Zalfa, S Paust |
Frontiers in immunology | 2021 |
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
F Veglia, E Sanseviero, DI Gabrilovich |
Nature Reviews Immunology | 2021 |
Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer
EG Shackleton, HY Ali, M Khan, GA Pockley, SE McArdle |
Cancers | 2021 |
Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment
J Frosch, I Leontari, J Anderson |
Cancers | 2021 |
Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation
H Tao, M Liu, Y Wang, S Luo, Y Xu, B Ye, L Zheng, K Meng, L Li |
Frontiers in immunology | 2021 |
Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway
K Alicea-Torres, E Sanseviero, J Gui, J Chen, F Veglia, Q Yu, L Donthireddy, A Kossenkov, C Lin, S Fu, C Mulligan, B Nam, G Masters, F Denstman, J Bennett, N Hockstein, A Rynda-Apple, Y Nefedova, SY Fuchs, DI Gabrilovich |
Nature Communications | 2021 |
Targeting myeloid-derived suppressor cells for cancer therapy
H Tang, H Li, Z Sun |
Cancer biology & medicine | 2021 |
Immunopathogenesis of Craniotomy Infection and Niche-Specific Immune Responses to Biofilm
SD de Morais, G Kak, JP Menousek, T Kielian |
Frontiers in immunology | 2021 |
Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects
T Li, T Liu, W Zhu, S Xie, Z Zhao, B Feng, H Guo, R Yang |
Clinical Medicine Insights. Oncology | 2021 |
Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases
Z Ling, C Yang, J Tan, C Dou, Y Chen |
Cellular and Molecular Life Sciences | 2021 |
Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis
H Zhu, JD Klement, C Lu, PS Redd, D Yang, AD Smith, DB Poschel, J Zou, D Liu, PG Wang, D Ostrov, N Coant, YA Hannun, AH Colby, MW Grinstaff, K Liu |
Journal of immunology (Baltimore, Md. : 1950) | 2021 |
Crosstalk Between the Tumor Microenvironment and Cancer Cells: A Promising Predictive Biomarker for Immune Checkpoint Inhibitors
X Li, Y Yang, Q Huang, Y Deng, F Guo, G Wang, M Liu |
Frontiers in Cell and Developmental Biology | 2021 |
Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer
J Chen, HW Sun, YY Yang, HT Chen, XJ Yu, WC Wu, YT Xu, LL Jin, XJ Wu, J Xu, L Zheng |
Signal Transduction and Targeted Therapy | 2021 |
Granulocytes and Cells of Granulocyte Origin—The Relevant Players in Colorectal Cancer
I Siemińska, E Poljańska, J Baran |
International journal of molecular sciences | 2021 |
Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion
X Li, J Chen, YJ Chen, YD Qiao, LY Zhao, N Jiang, XY Wu, YF Xing |
2021 | |
MDSC: Markers, development, states, and unaddressed complexity
S Hegde, AM Leader, M Merad |
Immunity | 2021 |
GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy
PB Ancey, C Contat, G Boivin, S Sabatino, J Pascual, N Zangger, JY Perentes, S Peters, ED Abel, DG Kirsch, JC Rathmell, MC Vozenin, E Meylan |
Cancer research | 2021 |
Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes
Y Wang, T Zhang, M Sun, X Ji, M Xie, W Huang, L Xia |
Cancers | 2021 |
Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection
MM Yaseen, NM Abuharfeil, H Darmani |
Open Biology | 2021 |
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
SA Nalawade, P Shafer, P Bajgain, MK McKenna, A Ali, L Kelly, J Joubert, S Gottschalk, N Watanabe, A Leen, R Parihar, JF Valdes, V Hoyos |
Journal for ImmunoTherapy of Cancer | 2021 |
Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer
Alessio Ugolini, Vladimir Tyurin, Yulia Tyurina, Evgenii Tsyganov, Laxminarasimha Donthireddy, Valerian E Kagan, Dmitry I. Gabrilovich, Filippo Veglia |
JCI Insight | 2020 |
Autocrine IL6-Mediated Activation of the STAT3–DNMT Axis Silences the TNFα–RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells
AD Smith, C Lu, D Payne, AV Paschall, JD Klement, PS Redd, ML Ibrahim, D Yang, Q Han, Z Liu, H Shi, TJ Hartney, A Nayak-Kapoor, K Liu |
Cancer research | 2020 |
Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy
P Innamarato, K Kodumudi, S Asby, B Schachner, ML Hall, A Mackay, D Wiener, M Beatty, L Nagle, BC Creelan, AA Sarnaik, S Pilon-Thomas |
Molecular Therapy | 2020 |
Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer
E Lafont |
Cancers | 2020 |
Myeloid-driven mechanisms as barriers to antitumor CD8+ T cell activity
SH Colligan, SL Tzetzo, SI Abrams |
Molecular Immunology | 2020 |
The Engagement Between MDSCs and Metastases: Partners in Crime
R Trovato, S Canè, V Petrova, S Sartoris, S Ugel, FD Sanctis |
Frontiers in Oncology | 2020 |
The Emerging Roles of Endoplasmic Reticulum Stress in Balancing Immunity and Tolerance in Health and Diseases: Mechanisms and Opportunities
A Li, NJ Song, BP Riesenberg, Z Li |
Frontiers in immunology | 2020 |
Lifting the innate immune barriers to antitumor immunity
CV Rothlin, S Ghosh |
Journal for ImmunoTherapy of Cancer | 2020 |
Neutrophils as emerging therapeutic targets
T Németh, M Sperandio, A Mócsai |
Nature Reviews Drug Discovery | 2020 |
Reactive Myelopoiesis and the Onset of Myeloid-Mediated Immune Suppression: Implications for Adoptive Cell Therapy
P Innamarato, S Pilon-Thomas |
Cellular Immunology | 2020 |
IRE1α regulates macrophage polarization, PD-L1 expression, and tumor survival
A Batista, JJ Rodvold, S Xian, SC Searles, A Lew, T Iwawaki, G Almanza, TC Waller, J Lin, K Jepsen, H Carter, M Zanetti, TC Freeman |
PLoS Biology | 2020 |
Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity
X Qin, WD Denton, LN Huiting, KS Smith, H Feng |
Critical Reviews in Biochemistry and Molecular Biology | 2020 |
The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
Y Mi, N Guo, J Luan, J Cheng, Z Hu, P Jiang, W Jin, X Gao |
Frontiers in immunology | 2020 |
Neutrophil diversity and plasticity in tumour progression and therapy
S Jaillon, A Ponzetta, DD Mitri, A Santoni, R Bonecchi, A Mantovani |
Nature Reviews Cancer | 2020 |
The complexity of neutrophils in health and disease: Focus on cancer
S Carnevale, S Ghasemi, A Rigatelli, S Jaillon |
Seminars in Immunology | 2020 |
Interplay between endoplasmic reticulum stress and non-coding RNAs in cancer
T Zhao, J Du, H Zeng |
Journal of Hematology & Oncology | 2020 |
Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation
Y Yang, C Li, T Liu, X Dai, AV Bazhin |
Frontiers in immunology | 2020 |
Myeloid-Derived Suppressor Cells in Colorectal Cancer
I Sieminska, J Baran |
Frontiers in immunology | 2020 |
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
PD Cicco, G Ercolano, A Ianaro |
Frontiers in immunology | 2020 |
Endoplasmic reticulum stress signals in the tumour and its microenvironment
, JR Cubillos-Ruiz |
Nature Reviews Cancer | 2020 |
Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
S Jin, Z Yang, X Hao, W Tang, W Ma, H Zong |
Biomarker Research | 2020 |
Developmental Pathways of Myeloid-Derived Suppressor Cells in Neoplasia
SI Abrams |
Cellular Immunology | 2020 |
Transmissible Endoplasmic Reticulum Stress: A Novel Perspective on Tumor Immunity
Z Jiang, G Zhang, L Huang, Y Yuan, C Wu, Y Li |
Frontiers in Cell and Developmental Biology | 2020 |
Myeloid-derived suppressor cells—new and exciting players in lung cancer
Z Yang, J Guo, L Weng, W Tang, S Jin, W Ma |
Journal of Hematology & Oncology | 2020 |
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling
E Mohamed, RA Sierra, J Trillo-Tinoco, Y Cao, P Innamarato, KK Payne, A de Mingo Pulido, J Mandula, S Zhang, P Thevenot, S Biswas, SK Abdalla, TL Costich, K Hänggi, CM Anadon, ER Flores, EB Haura, S Mehrotra, S Pilon-Thomas, B Ruffell, DH Munn, JR Cubillos-Ruiz, JR Conejo-Garcia, PC Rodriguez |
Immunity | 2020 |
ER Stress Regulates Immunosuppressive Function of Myeloid Derived Suppressor Cells in Leprosy that Can Be Overcome in the Presence of IFN-γ
KM Kelly-Scumpia, A Choi, R Shirazi, H Bersabe, E Park, PO Scumpia, MT Ochoa, J Yu, F Ma, M Pellegrini, RL Modlin |
iScience | 2020 |
KSHV infection skews macrophage polarisation towards M2-like/TAM and activates Ire1 α-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression
MS Montani, L Falcinelli, R Santarelli, M Granato, MA Romeo, N Cecere, R Gonnella, G DOrazi, A Faggioni, M Cirone |
British Journal of Cancer | 2020 |
The future of cancer immunotherapy: microenvironment-targeting combinations
YR Murciano-Goroff, AB Warner, JD Wolchok |
Cell Research | 2020 |
Dyslipidemic Diet Induces Mobilization of Peripheral Neutrophils and Monocytes That Exacerbate Hemorrhagic Brain Injury and Neuroinflammation
X Li, X Cheng, X Wang, Q Liu, H Ma, M Li |
Frontiers in cellular neuroscience | 2020 |
Upregulated TRAIL and Reduced DcR2 Mediate Apoptosis of Decidual PMN-MDSC in Unexplained Recurrent Pregnancy Loss
C Li, X Zhang, X Kang, C Chen, F Guo, Q Wang, A Zhao |
Frontiers in immunology | 2020 |
Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells
Q Li, Q Ran, L Sun, J Yin, T Luo, L Liu, Z Zhao, Q Yang, Y Li, Y Chen, X Weng, Y Wang, W Cai, X Zhu |
Frontiers in pharmacology | 2020 |
The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative
N Karin |
Frontiers in immunology | 2020 |
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma
Yu SJ, Greten TF |
2020 | |
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC
Julia Kargl, Xiaodong Zhu, Huajia Zhang, grace hy yang, Travis J Friesen, melissa shipley, Dean Y. Maeda, John A. Zebala, Jill McKay-Fleisch, Gavin Meredith, Afshin Mashadi-Hossein, Christina Baik, Robert H. Pierce, Mary W Redman, Jeffrey C. Thompson, Steven M Albelda, Hamid Bolouri, A McGarry Houghton |
JCI Insight | 2019 |
TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity
Rossin, Miloro, Hueber |
Cancers | 2019 |
Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives LC Lu, CJ Chang, CH Hsu |
Journal of Hepatocellular Carcinoma | 2019 |
Proteostasis In The Endoplasmic Reticulum: Road to Cure
Nam, Jeon |
Cancers | 2019 |
The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses
D Sag, ZO Ayyildiz, S Gunalp, G Wingender |
Cancers | 2019 |
Immunosurveillance of cancer cell stress
S Lorenzo-Herrero, C Sordo-Bahamonde, S González, A López-Soto |
2019 | |
Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells
MR Goulart, SI Hlavaty, YM Chang, G Polton, A Stell, J Perry, Y Wu, E Sharma, J Broxholme, AC Lee, B Szladovits, M Turmaine, J Gribben, D Xia, OA Garden |
Scientific Reports | 2019 |
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment
MJ Halaby, K Hezaveh, S Lamorte, MT Ciudad, A Kloetgen, BL MacLeod, M Guo, A Chakravarthy, TD Medina, S Ugel, A Tsirigos, V Bronte, DH Munn, TJ Pugh, DD Carvalho, MO Butler, PS Ohashi, DG Brooks, TL McGaha |
Science Immunology | 2019 |
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
Y Cao, J Trillo-Tinoco, RA Sierra, C Anadon, W Dai, E Mohamed, L Cen, TL Costich, A Magliocco, D Marchion, R Klar, S Michel, F Jaschinski, RR Reich, S Mehrotra, JR Cubillos-Ruiz, DH Munn, JR Conejo-Garcia, PC Rodriguez |
Nature Communications | 2019 |
MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
Y Wang, Y Ding, N Guo, S Wang |
Frontiers in immunology | 2019 |
Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
X Tian, H Shen, Z Li, T Wang, S Wang |
Journal of Hematology & Oncology | 2019 |
Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
A Thyagarajan, MS Alshehri, KL Miller, CM Sherwin, JB Travers, RP Sahu |
Cancers | 2019 |
Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice
T Kawano, M Shimamura, H Nakagami, H Kanki, T Sasaki, H Mochizuki, M Mogi |
PloS one | 2019 |
Myeloid Derived Suppressor Cells Expansion Persists After Early ART and May Affect CD4 T Cell Recovery
C Agrati, N Tumino, V Bordoni, C Pinnetti, A Sabatini, A Amendola, I Abbate, P Lorenzini, A Mondi, R Casetti, E Cimini, G Grassi, A Antinori, A Sacchi |
Frontiers in immunology | 2019 |
Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
L Cassetta, ES Baekkevold, S Brandau, A Bujko, MA Cassatella, A Dorhoi, C Krieg, A Lin, K Loré, O Marini, JW Pollard, M Roussel, P Scapini, V Umansky, GJ Adema |
Cancer Immunology, Immunotherapy | 2019 |
Polymorphonuclear myeloid-derived suppressor cells attenuate allergic airway inflammation by negatively regulating group 2 innate lymphoid cells
Y Cao, Y He, X Wang, Y Liu, K Shi, Z Zheng, X Su, A Lei, J He, J Zhou |
Immunology | 2019 |
Endoplasmic Reticulum Stress Contributes to Mitochondrial Exhaustion of CD8 + T Cells
KE Hurst, KA Lawrence, MT Essman, ZJ Walton, LR Leddy, JE Thaxton |
Cancer immunology research | 2019 |
The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc
H Dong, NM Adams, Y Xu, J Cao, DS Allan, JR Carlyle, , JC Sun, LH Glimcher |
Nature Immunology | 2019 |
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs
M Bosiljcic, RA Cederberg, MJ Hamilton, NE LePard, BT Harbourne, JL Collier, EC Halvorsen, R Shi, SE Franks, AY Kim, JP Banáth, M Hamer, FM Rossi, KL Bennewith |
Breast Cancer Research | 2019 |
Bacterial Killing Activity of Polymorphonuclear Myeloid-Derived Suppressor Cells Isolated From Tumor-Bearing Dogs
SI Hlavaty, YM Chang, RP Orth, M Goulian, PJ Planet, DH Thamm, JA Punt, OA Garden |
Frontiers in immunology | 2019 |
Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma
Xu, Yang, Yang, Berezowska, Gao, Liang, Marti, Hall, Dorn, Kocher, Schmid, Peng |
Cancers | 2019 |
The inhibitor of autophagy SBI‑0206965 aggravates atherosclerosis through decreasing myeloid‑derived suppressor cells
B Wang, G Dong, Q Zhang, F Yan, Z Li, C Li, H Zhang, Q Ma, J Dai, C Si, H Xiong |
Experimental and therapeutic medicine | 2019 |
Pharmacological Targeting of MYC-Regulated IRE1/XBP1 Pathway Suppresses MYC-Driven Breast Cancer
Na Zhao, Jin Cao, Longyong Xu, Qianzi Tang, Lacey Dobrolecki, Xiangdong Lyu, Manisha Talukdar, Yang Lu, Xiaoran Wang, Dorothy Hu, Qing Shi, Yu Xiang, Yunfei Wang, Xia Liu, Wen Bu, Yi Jiang, Mingzhou Li, Yingyun Gong, Zheng Sun, Haoqiang Ying, Bo Yuan, Xia Lin, Xin-Hua Feng, Sean Hartig, Feng Li, Haifa Shen, Yiwen Chen, Leng Han, Qingping Zeng, John Patterson, Benny Abraham Kaipparettu, NAGIREDDY PUTLURI, Frank Sicheri, Jeffrey Rosen, Michael T. Lewis, Xi Chen |
Journal of Clinical Investigation | 2018 |
Spleen Mediates A Distinct Hematopoietic Progenitor Response Supporting Tumor-Promoting Myelopoiesis
Chong Wu, Huiheng Ning, Mingyu Liu, Jie Lin, Shufeng Luo, Wenjie Zhu, Jing Xu, Wen-Chao Wu, Jing Liang, Chun-Kui Shao, Jiaqi Ren, Bin Wei, Jun Cui, Min-Shan Chen, Limin Zheng |
Journal of Clinical Investigation | 2018 |
Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells
Themis Alissafi, Aikaterini Hatzioannou, Konstantinos Mintzas, Roza Maria Barouni, Aggelos Banos, Sundary Sormendi, Alexandros Polyzos, Maria Xilouri, Ben Wielockx, Helen Gogas, Panayotis Verginis |
Journal of Clinical Investigation | 2018 |
Distal airway microbiome is associated with immunoregulatory myeloid cell responses in lung transplant recipients
NS Sharma, KM Wille, S Athira, D Zhi, KP Hough, E Diaz-Guzman, K Zhang, R Kumar, S Rangarajan, P Eipers, Y Wang, RK Srivastava, JV Dager, M Athar, C Morrow, CW Hoopes, DD Chaplin, VJ Thannickal, JS Deshane |
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation | 2018 |
Plasticity of myeloid-derived suppressor cells in cancer
E Tcyganov, J Mastio, E Chen, DI Gabrilovich |
Current Opinion in Immunology | 2018 |
Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation
YM He, X Li, M Perego, Y Nefedova, AV Kossenkov, EA Jensen, V Kagan, YF Liu, SY Fu, QJ Ye, YH Zhou, L Wei, DI Gabrilovich, J Zhou |
Nature Medicine | 2018 |
Protein Quality Control in the Endoplasmic Reticulum and Cancer
HW Moon, HG Han, YJ Jeon |
International journal of molecular sciences | 2018 |
S100A4 Protects Myeloid-Derived Suppressor Cells from Intrinsic Apoptosis via TLR4–ERK1/2 Signaling
Q Li, C Dai, R Xue, P Wang, L Chen, Y Han, U Erben, Z Qin |
Frontiers in immunology | 2018 |
Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
N du Plessis, LA Kotze, V Leukes, G Walzl |
Frontiers in Cellular and Infection Microbiology | 2018 |
The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates
E Mohamed, AA Al-Khami, PC Rodriguez |
Cellular and Molecular Immunology | 2018 |
Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
A Dorhoi, ND Plessis |
Frontiers in immunology | 2018 |
Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
J Zhou, Y Nefedova, A Lei, D Gabrilovich |
Seminars in Immunology | 2018 |
Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
S Ostrand-Rosenberg, C Fenselau |
Journal of immunology (Baltimore, Md. : 1950) | 2018 |
Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
EJ Clappaert, A Murgaski, HV Damme, M Kiss, D Laoui |
Frontiers in immunology | 2018 |
Myeloid-derived suppressor cells coming of age
F Veglia, M Perego, D Gabrilovich |
Nature Immunology | 2018 |
Inhibition of Casein Kinase 2 Disrupts Differentiation of Myeloid Cells in Cancer and Enhances the Efficacy of Immunotherapy in Mice
A Hashimoto, C Gao, J Mastio, A Kossenkov, SI Abrams, AV Purandare, H Desilva, S Wee, J Hunt, M Jure-Kunkel, DI Gabrilovich |
Cancer research | 2018 |
Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension
AJ Bryant, V Shenoy, C Fu, G Marek, KJ Lorentsen, EL Herzog, ML Brantly, D Avram, EW Scott |
American journal of respiratory cell and molecular biology | 2018 |
Unique pattern of neutrophil migration and function during tumor progression
S Patel, S Fu, J Mastio, GA Dominguez, A Purohit, A Kossenkov, C Lin, K Alicea-Torres, M Sehgal, Y Nefedova, J Zhou, LR Languino, C Clendenin, RH Vonderheide, C Mulligan, B Nam, N Hockstein, G Masters, M Guarino, ZT Schug, DC Altieri, DI Gabrilovich |
Nature Immunology | 2018 |
Tumor regulation of the tissue environment in the liver
T Eggert, TF Greten |
Pharmacology & Therapeutics | 2017 |
Unfolded Protein Response of the Endoplasmic Reticulum in Tumor Progression and Immunogenicity
YS Yoo, HG Han, YJ Jeon |
Oxidative medicine and cellular longevity | 2017 |
IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer
Q Yang, X Li, H Chen, Y Cao, Q Xiao, Y He, J Wei, J Zhou |
Oncogene | 2017 |
Myeloid-Derived Suppressor Cells
DI Gabrilovich |
Cancer immunology research | 2017 |
Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer
JR Cubillos-Ruiz, SE Bettigole, LH Glimcher |
Cell | 2017 |
Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis
SL Jian, WW Chen, YC Su, YW Su, TH Chuang, SC Hsu, LR Huang |
Cell Death and Disease | 2017 |
Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation
BH Koehn, BR Blazar |
Journal of leukocyte biology | 2017 |
IRF-8 regulates expansion of myeloid-derived suppressor cells and Foxp3+ regulatory T cells and modulates Th2 immune responses to gastrointestinal nematode infection
RM Valanparambil, M Tam, PP Gros, JP Auger, M Segura, P Gros, A Jardim, TG Geary, K Ozato, MM Stevenson, P Loke |
PLoS pathogens | 2017 |
SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells
PS Redd, ML Ibrahim, JD Klement, SK Sharman, AV Paschall, D Yang, A Nayak-Kapoor, K Liu |
Cancer research | 2017 |
Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer
JR Cubillos-Ruiz, E Mohamed, PC Rodriguez |
Journal for ImmunoTherapy of Cancer | 2017 |
Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy
E Mohamed, Y Cao, PC Rodriguez |
Cancer Immunology, Immunotherapy | 2017 |
First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors
A Forero, JC Bendell, P Kumar, L Janisch, M Rosen, Q Wang, C Copigneaux, M Desai, G Senaldi, ML Maitland |
Investigational New Drugs | 2017 |
Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells
JJ Rodvold, KT Chiu, N Hiramatsu, JK Nussbacher, V Galimberti, NR Mahadevan, K Willert, JH Lin, M Zanetti |
Science signaling | 2017 |
Selective NLRP3 (Pyrin Domain–Containing Protein 3) Inflammasome Inhibitor Reduces Brain Injury After Intracerebral Hemorrhage
H Ren, Y Kong, Z Liu, D Zang, X Yang, K Wood, M Li, Q Liu |
Stroke; a journal of cerebral circulation | 2017 |
Endoplasmic reticulum stress induced LOX-1 + CD15 + polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma
J Nan, YF Xing, B Hu, JX Tang, HM Dong, YM He, DY Ruan, QJ Ye, JR Cai, XK Ma, J Chen, XR Cai, ZX Lin, XY Wu, X Li |
Immunology | 2017 |
Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies
Z Lopez-Bujanda, CG Drake |
Journal of leukocyte biology | 2017 |
Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
GA Dominguez, T Condamine, S Mony, A Hashimoto, F Wang, Q Liu, A Forero, J Bendell, R Witt, N Hockstein, P Kumar, DI Gabrilovich |
Clinical cancer research | 2016 |
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
V Bronte, S Brandau, SH Chen, MP Colombo, AB Frey, TF Greten, S Mandruzzato, PJ Murray, A Ochoa, S Ostrand-Rosenberg, PC Rodriguez, A Sica, V Umansky, RH Vonderheide, DI Gabrilovich |
Nature Communications | 2016 |
Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy
IR Ramachandran, T Condamine, C Lin, SE Herlihy, A Garfall, DT Vogl, DI Gabrilovich, Y Nefedova |
Cancer Letters | 2016 |
High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy
KH Parker, LA Horn, S Ostrand-Rosenberg |
Journal of leukocyte biology | 2016 |
Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2
DW Beury, KA Carter, C Nelson, P Sinha, E Hanson, M Nyandjo, PJ Fitzgerald, A Majeed, N Wali, S Ostrand-Rosenberg |
Journal of immunology (Baltimore, Md. : 1950) | 2016 |
Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer
C Camisaschi, V Vallacchi, E Vergani, M Tazzari, S Ferro, A Tuccitto, O Kuchuk, E Shahaj, R Sulsenti, C Castelli, M Rodolfo, L Rivoltini, V Huber |
Human vaccines | 2016 |
Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis
CB Hergott, AM Roche, E Tamashiro, TB Clarke, AG Bailey, A Laughlin, FD Bushman, JN Weiser |
Blood | 2016 |
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
T Condamine, GA Dominguez, JI Youn, AV Kossenkov, S Mony, K Alicea-Torres, E Tcyganov, A Hashimoto, Y Nefedova, C Lin, S Partlova, A Garfall, DT Vogl, X Xu, SC Knight, G Malietzis, GH Lee, E Eruslanov, SM Albelda, X Wang, JL Mehta, M Bewtra, A Rustgi, N Hockstein, R Witt, G Masters, B Nam, D Smirnov, MA Sepulveda, DI Gabrilovich |
Science Immunology | 2016 |
Myeloid-Derived Suppressor Cells in Bacterial Infections
M Ost, A Singh, A Peschel, R Mehling, N Rieber, D Hartl |
Frontiers in Cellular and Infection Microbiology | 2016 |
Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells
F Liu, X Li, C Lu, A Bai, J Bielawski, A Bielawska, B Marshall, PV Schoenlein, IO Lebedyeva, K Liu |
Oncotarget | 2016 |
Primary Heligmosomoides polygyrus bakeri infection induces myeloid-derived suppressor cells that suppress CD4+ Th2 responses and promote chronic infection
RM Valanparambil, M Tam, A Jardim, TG Geary, MM Stevenson |
Mucosal Immunology | 2016 |
TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide
F Yang, Y Li, T Wu, N Na, Y Zhao, W Li, C Han, L Zhang, J Lu, Y Zhao |
Journal of Molecular Medicine | 2016 |
TNF-related apoptosis-inducing ligand deficiency enhances survival in murine colon ascendens stent peritonitis
K Beyer, L Stollhof, C Poetschke, W Bernstorff, LI Partecke, S Diedrich, S Maier, B Broeker, CD Heidecke |
Journal of inflammation research | 2016 |
Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment
M Liguori, C Buracchi, F Pasqualini, F Bergomas, S Pesce, M Sironi, F Grizzi, A Mantovani, C Belgiovine, P Allavena |
Oncotarget | 2016 |
Myeloid-derived suppressor cells in the tumor microenvironment: things are not always what they seem
Douglas Marvel, Dmitry I. Gabrilovich |
Journal of Clinical Investigation | 2015 |
Transcriptional regulation of myeloid-derived suppressor cells
T Condamine, J Mastio, DI Gabrilovich |
Journal of leukocyte biology | 2015 |
The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells
M Zanetti, JJ Rodvold, NR Mahadevan |
Oncogene | 2015 |
The phenotype, development and biological function of myeloid-derived suppressor cells: Molecular regulation of MDSCs
Y Zhao, T Wu, S Shao, B Shi, Y Zhao |
OncoImmunology | 2015 |
The immunobiology of myeloid-derived suppressor cells in cancer
M Motallebnezhad, F Jadidi-Niaragh, ES Qamsari, S Bagheri, T Gharibi, M Yousefi |
Tumor Biology | 2015 |
Advances in Cancer Research
MR Rutkowski, N Svoronos, A Perales-Puchalt, JR Conejo-Garcia |
Advances in cancer research | 2015 |
Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancer
J Yang, J Wei, Y Wu, Z Wang, Y Guo, P Lee, X Li |
Oncogenesis | 2015 |
Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease
YJ Kim, SY Chang, HJ Ko |
Intestinal Research | 2015 |
Antigen spreading-induced CD8+T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells
Yu Z, Tan Z, Lee BK, Tang J, Wu X, Cheung KW, Lok Lo NT, Man K, Liu L, Chen Z |
Oncotarget | 2015 |
The impact of the endoplasmic reticulum protein-folding environment on cancer development
M Wang, RJ Kaufman |
Nature Reviews Cancer | 2014 |
The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors
PT Thevenot, RA Sierra, PL Raber, AA Al-Khami, J Trillo-Tinoco, P Zarreii, AC Ochoa, Y Cui, L Del Valle, PC Rodriguez |
Immunity | 2014 |
Myeloid-Derived Suppressor Activity Is Mediated by Monocytic Lineages Maintained by Continuous Inhibition of Extrinsic and Intrinsic Death Pathways
JM Haverkamp, AM Smith, R Weinlich, CP Dillon, JE Qualls, G Neale, B Koss, Y Kim, V Bronte, MJ Herold, DR Green, JT Opferman, PJ Murray |
Immunity | 2014 |
Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
KD Veirman, EV Valckenborgh, Q Lahmar, X Geeraerts, ED Bruyne, E Menu, IV Riet, K Vanderkerken, JA van Ginderachter |
Frontiers in Oncology | 2014 |
Characterization of the Murine Myeloid Precursor Cell Line MuMac-E8
S Fricke, C Pfefferkorn, D Wolf, S Riemschneider, J Kohlschmidt, N Hilger, C Fueldner, J Knauer, U Sack, F Emmrich, J Lehmann, P Rameshwar |
PloS one | 2014 |
A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice
Liechtenstein T, Perez-Janices N, Gato M, Caliendo F, Kochan G, Blanco-Luquin I, Van der Jeught K, Arce F, Guerrero-Setas D, Fernandez-Irigoyen J, Santamaria E, Breckpot K, Escors D |
Oncotarget | 2014 |